InvestorsHub Logo
Followers 2
Posts 2154
Boards Moderated 0
Alias Born 08/17/2006

Re: keitern post# 162

Monday, 11/19/2007 7:50:53 AM

Monday, November 19, 2007 7:50:53 AM

Post# of 400
LOL Keitern - for the sake of others who may be reading this board and not to argue with you personally, I have no motive. Someone posted an article that mentioned a success of the portion of the business that was sold. I asked a question about it, and a small conversation began.

Then you started suggesting that because 8 companies had agreed to allow GLGC to look into repositioning their failed drugs, that must mean something...

You then went on to suggest that these agreements represented a significant inventment and level of trust in GLGC on the part of the drug companies.

For the sake of others who may be reading this board, I pointed out that the company itself views these agreements as low risk for the drug companies....i.e., no big deal.....that's all

Even your most recent post backs that up...indicating that only in"some cases" does the drug company even actually "share expenses" as they occur....what ever that means.

For others who may be jumping into this conversation late:

From GLGC Web Site:

Gene Logic provides the pharmaceutical industry a unique cost-effective, low-risk partnering solution for finding new uses for their discontinued compounds, prioritizing the most promising lead candidates and finding the broadest therapeutic applications for a marketed compound lifecycle. Our partnerships are flexible, full service collaborations providing pharmaceutical companies the ability to share risk while working together to achieve success. Partners receive full access to our dedicated team of industry-leading drug developers and our comprehensive, multi-prong drug repositioning and selection technology platform.

DD source:

http://www.genelogic.com/aboutus/business.cfm

What's your motive?





Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.